MULTIPLY-SUBSTITUTED PROTEASE VARIANTS
    21.
    发明申请
    MULTIPLY-SUBSTITUTED PROTEASE VARIANTS 审中-公开
    多选取代蛋白质变体

    公开(公告)号:US20080176313A1

    公开(公告)日:2008-07-24

    申请号:US11929880

    申请日:2007-10-30

    摘要: Novel enzyme variants including protease variants derived from the DNA sequences of naturally-occurring or recombinant non-human proteases are disclosed. The variant proteases, in general are obtained by in vitro modification of a precursor DNA sequence encoding the naturally-occurring or recombinant protease to generate the substitution of a plurality of amino acid residues in the amino acid sequence of a precursor protease. Such variant proteases have properties which are different from those of the precursor protease, such as altered wash performance. The substituted amino acid residue correspond to positions 27, 45, 170, 181, 251 and 271 of Bacillus amyloliquefaciens subtilisin. Additional variants comprising at least one additional substitution at a position selected from 1, 14, 49, 61, 87, 100, 102, 118, 128, 204 and 258 of Bacillus amyloliquefaciens subtilisin are also described.

    摘要翻译: 公开了包含衍生自天然或重组非人蛋白酶的DNA序列的蛋白酶变体的新型酶变体。 变体蛋白酶一般通过体外修饰编码天然存在或重组蛋白酶的前体DNA序列获得,以产生前体蛋白酶的氨基酸序列中的多个氨基酸残基的取代。 这种变体蛋白酶具有与前体蛋白酶不同的性质,例如改变的洗涤性能。 取代的氨基酸残基对应于解淀粉芽孢杆菌枯草杆菌蛋白酶的位置27,45,170,181,251和271。 还描述了包含在解淀粉芽孢杆菌枯草杆菌蛋白酶的1,4,14,69,61,87,100,102,118,128,204和258的位置上的至少一个另外的取代的其它变体。

    MULTIPLY-SUBSTITUTED PROTEASE VARIANTS
    23.
    发明申请
    MULTIPLY-SUBSTITUTED PROTEASE VARIANTS 审中-公开
    多选取代蛋白质变体

    公开(公告)号:US20080124783A1

    公开(公告)日:2008-05-29

    申请号:US11929907

    申请日:2007-10-30

    摘要: Novel enzyme variants including protease variants derived from the DNA sequences of naturally-occurring or recombinant non-human proteases are disclosed. The variant proteases, in general, are obtained by in vitro modification of a precursor DNA sequence encoding the naturally-occurring or recombinant protease to generate the substitution of a plurality of amino acid residues in the amino acid sequence of a precursor protease. Such variant proteases have properties which are different from those of the precursor protease, such as altered wash performance. The substituted amino acid residue correspond to positions 27, 45, 170, 181, 251 and 271 of Bacillus amyloliquefaciens subtilisin. Additional variants comprising at least one additional substitution at a position selected from 1, 14, 49, 61, 87, 100, 102, 118, 128, 204 and 258 of Bacillus amyloliquefaciens subtilisin are also described.

    摘要翻译: 公开了包含衍生自天然或重组非人蛋白酶的DNA序列的蛋白酶变体的新型酶变体。 一般来说,变体蛋白酶通过体外修饰编码天然存在或重组蛋白酶的前体DNA序列获得,以产生前体蛋白酶的氨基酸序列中的多个氨基酸残基的取代。 这种变体蛋白酶具有与前体蛋白酶不同的性质,例如改变的洗涤性能。 取代的氨基酸残基对应于解淀粉芽孢杆菌枯草杆菌蛋白酶的位置27,45,170,181,251和271。 还描述了包含在解淀粉芽孢杆菌枯草杆菌蛋白酶的1,4,14,69,61,87,100,102,118,128,204和258的位置上的至少一个另外的取代的其它变体。

    Synthesis of glycodendrimer reagents
    25.
    发明授权
    Synthesis of glycodendrimer reagents 有权
    糖苷配基试剂的合成

    公开(公告)号:US06627744B2

    公开(公告)日:2003-09-30

    申请号:US09824827

    申请日:2001-04-02

    IPC分类号: C07H1700

    摘要: The present invention relates to a chemically modified mutant protein including a cysteine residue substituted for a residue other than cysteine n a precursor protein, the substituted cysteine residue being subsequently modified by reacting the cysteine residue with a glycosylated thiosulfonate. Also a method of producing the chemically modified mutant protein is provided. The present invention also relates to a glycosylated methanethiosulfonate. Another aspect of the present invention is a method of modifying the functional characteristics of a protein including providing a protein and reacting the protein with a glycosylated methanethiosulfonate reagent under conditions effective to produce a glycoprotein with altered functional characteristics as compared to the protein. In addition, the present invention relates to methods of determining the structure-function relationships of chemically modified mutant proteins. The present invention also relates to synthetic methods for producing thio-glycoses, the thio-glycoses so produced, and to methods for producing glycodendrimer reagents.

    摘要翻译: 本发明涉及一种化学修饰的突变蛋白,其包含半胱氨酸残基,其取代了半胱氨酸以外的残基而不是前体蛋白,随后通过半胱氨酸残基与糖基化硫代磺酸酯反应来修饰取代的半胱氨酸残基。 还提供了一种生产化学修饰的突变蛋白的方法。 本发明还涉及糖基化甲磺酸盐。 本发明的另一方面是一种改变蛋白质的功能特征的方法,包括提供蛋白质并使蛋白质与糖基化甲磺酸盐试剂在与蛋白质相比产生具有改变的功能特征的糖蛋白的条件下反应。 此外,本发明涉及确定化学修饰的突变蛋白的结构 - 功能关系的方法。 本发明还涉及用于制备硫代糖糖,如此制备的硫代糖糖的合成方法,以及制备糖苷配基体试剂的方法。

    Subtilisin variants multiply-substituted subtilising variants having a substitution at position 76
    26.
    发明授权
    Subtilisin variants multiply-substituted subtilising variants having a substitution at position 76 失效
    枯草杆菌蛋白酶变体在第76位具有取代的多取代的枯草芽孢杆菌变体

    公开(公告)号:US06586221B2

    公开(公告)日:2003-07-01

    申请号:US08322678

    申请日:1994-10-13

    IPC分类号: C12N950

    CPC分类号: C11D3/38609 C12N9/54

    摘要: Novel carbonyl hydrolase variants derived from the DNA sequences of naturally-occurring or recombinant non-human carbonyl hydrolases are disclosed. The variant carbonyl hydrolases, in general, are obtained by in vitro modification of a precursor DNA sequence encoding the naturally-occurring or recombinant carbonyl hydrolase to generate the substitution of a plurality of amino acid residues in the amino acid sequence of a precursor carbonyl hydrolase. Such variant carbonyl hydrolases have properties which are different from those of the precursor hydrolase, such as altered proteolytic activity, altered stability, etc. The substituted amino acid residues correspond to positions +76 in combination with one or more of the following residues +99, +101, +103, +104, +107, +123, +27, +105, +109, +126, +128, +135, +156, +166, +195, +197, +204, +206, +210, +216, +217, +218, +222, +260, +265 and/or +274 in Bacillus amyloliquefaciens subtilisin.

    摘要翻译: 公开了衍生自天然存在或重组非人羰基水解酶的DNA序列的新型羰基水解酶变体。 变体羰基水解酶通常通过体外修饰编码天然存在或重组羰基水解酶的前体DNA序列获得,以产生前体羰基水解酶的氨基酸序列中的多个氨基酸残基的取代。 这种变体羰基水解酶具有与前体水解酶不同的性质,例如改变的蛋白水解活性,改变的稳定性等。取代的氨基酸残基对应于与一个或多个以下残基组合的位置+76, +101,+103,+104,+107,+123,+27,+105,+ 109,+126,+128,+135,+ 156,+166,+ 195,+ 197,+ 204,+ 206 ,+210,+ 216,+ 217,+ 218,+ 222,+ 260,+ 265和/或+ 274的解淀粉芽孢杆菌枯草杆菌蛋白酶。

    Specifically targeted catalytic antagonists and uses thereof
    29.
    发明授权
    Specifically targeted catalytic antagonists and uses thereof 失效
    特异性靶向催化拮抗剂及其用途

    公开(公告)号:US08431121B2

    公开(公告)日:2013-04-30

    申请号:US12953378

    申请日:2010-11-23

    IPC分类号: A61K38/48

    摘要: This invention provides chimeric molecules that are catalytic antagonists of a target molecule. The catalytic antagonists of this invention preferably comprise a targeting moiety attached to an enzyme that degrades the molecule specifically bound by the targeting moiety. The catalytic antagonists of this invention thus bind to a target recognized by the targeting moiety (e.g., a receptor) the enzyme component of the chimera then degrades all or part of the target. This typically results in a reduction or loss of activity of the target and release of the chimeric molecule. The chimeric molecule is then free to attack and degrade another target molecule.

    摘要翻译: 本发明提供作为靶分子的催化拮抗剂的嵌合分子。 本发明的催化拮抗剂优选包含与降解由靶向部分特异性结合的分子的酶连接的靶向部分。 因此,本发明的催化拮抗剂与靶向部分识别的靶(例如受体)结合,嵌合体的酶组分然后降解靶的全部或部分。 这通常导致靶的活性降低或丧失,并释放嵌合分子。 然后嵌合分子可以自由地攻击和降解另一个靶分子。